Evidence map›Paper›PMID 39982801›Full record

ArticleKidney3602025

Analysis of Cardiovascular and Cerebrovascular Prognosis and Risk Factors in Patients with Primary Membranous Nephropathy.

Nan Ye, Lei Yang, Guoqin Wang, Wenrong Cheng, Bing Xie, Hongrui Dong, Lingqiang Kong, Xiaoyi Zhao, Yanqiu Geng, Hong Cheng

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Kidney360, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Nan YeRenal Division, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.ORCID 0000-0001-9339-9361
Lei YangRenal Division, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Guoqin WangRenal Division, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.ORCID 0000-0001-7288-6830
Wenrong ChengRenal Division, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.ORCID 0000-0003-4802-9315
Bing XieRenal Division, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Hongrui DongRenal Division, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Lingqiang KongRenal Division, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Xiaoyi ZhaoRenal Division, Affiliated Hospital of Chifeng University, Neimenggu, China.
Yanqiu GengRenal Division, Third Medical Center, Chinese PLA General Hospital, Beijing, China.
Hong ChengRenal Division, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.ORCID 0000-0002-7908-3333

Funding

Beijing Hospital Authority Young Talent Cultivation "Qingmiao" Program QML20230601Beijing Municipal Hospital Scientific Research and Cultivation Program PX2022024Special Project for Scientific Research on Health Development of the Capital 2022-2-2066
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

cardiovascular eventsmembranous nephropathy

Identifiers

PMID39982801
PMCPMC12233846

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.